ArticleLeukemia2012

Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia.

S Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.